A directed evolution approach to select for novel Adeno-associated virus capsids on an HIV-1 producer T cell line

Journal of Virological Methods

Volumn 250, Issue , 2017, Pages 47-54

  Wooley, Dawn P ^a   Sharma, Priyanka ^b   Weinstein, John R ^c,d   Kotha Lakshmi Narayan, Poornima ^b,e   Schaffer, David V ^c   Excoffon, Katherine J D A ^b  

^a WRIGHT STATE UNIVERSITY   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

Author keywords

AAV; Directed evolution; Gene transfer; HIV 1; T cell

Indexed keywords

ADENO ASSOCIATED VIRUS; ARTICLE; CONTROLLED STUDY; DIRECTED MOLECULAR EVOLUTION; EMBRYO; GENE TRANSFER; GENETIC SELECTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRAL TROPISM; VIRUS CAPSID; VIRUS GENOME; CELL LINE; DEPENDOPARVOVIRUS; GENE LIBRARY; GENE VECTOR; GENETICS; HELA CELL LINE; ISOLATION AND PURIFICATION; MUTATION; PHYSIOLOGY; PROCEDURES; VIROLOGY; VIRUS UNCOATING;

CAPSID; CELL LINE; DEPENDOVIRUS; DIRECTED MOLECULAR EVOLUTION; GENE LIBRARY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HELA CELLS; HIV-1; HUMANS; MUTATION; T-LYMPHOCYTES; VIRAL TROPISM; VIRUS UNCOATING;

EID: 85030239829     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2017.09.008     Document Type: Article

References (69)

1. Antoni, B.A., Rabson, A.B., Miller, I.L., Trempe, J.P., Chejanovsky, N., Carter, B.J., Adeno-associated virus Rep protein inhibits human immunodeficiency virus type 1 production in human cells. J. Virol. 65 (1991), 396–404.
2. Bartlett, J.S., Kleinschmidt, J., Boucher, R.C., Samulski, R.J., Targeted Adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody. Nat. Biotechnol. 17 (1999), 181–186.
3. Berro, R., de la Fuente, C., Klase, Z., Kehn, K., Parvin, L., Pumfery, A., Agbottah, E., Vertes, A., Nekhai, S., Kashanchi, F., Identifying the membrane proteome of HIV-1 latently infected cells. J. Biol. Chem. 282 (2007), 8207–8218.
4. Bobbin, M.L., Burnett, J.C., Rossi, J.J., RNA interference approaches for treatment of HIV-1 infection. Genome Med., 7, 2015, 50.
5. Buning, H., Perabo, L., Coutelle, O., Quadt-Humme, S., Hallek, M., Recent developments in Adeno-associated virus vector technology. J. Gene Med. 10 (2008), 717–733.
6. Burger, C., Gorbatyuk, O.S., Velardo, M.J., Peden, C.S., Williams, P., Zolotukhin, S., Reier, P.J., Mandel, R.J., Muzyczka, N., Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol. Ther. 10 (2004), 302–317.
7. Chenine, A.L., Sattentau, Q., Moulard, M., Selective HIV-1-induced downmodulation of CD4 and coreceptors. Arch. Virol. 145 (2000), 455–471.
8. Choi, B., Gatti, P.J., Fermin, C.D., Vigh, S., Haislip, A.M., Garry, R.F., Down-regulation of cell surface CXCR4 by HIV-1. Virol. J., 5, 2008, 6.
9. Daya, S., Berns, K.I., Gene therapy using Adeno-associated virus vectors. Clin. Microbiol. Rev. 21 (2008), 583–593.
10. Dever, D.P., Bak, R.O., Reinisch, A., Camarena, J., Washington, G., Nicolas, C.E., Pavel-Dinu, M., Saxena, N., Wilkens, A.B., Mantri, S., Uchida, N., Hendel, A., Narla, A., Majeti, R., Weinberg, K.I., Porteus, M.H., CRISPR/Cas9 beta-globin gene targeting in human haematopoietic stem cells. Nature 539 (2016), 384–389.
11. DuBridge, R.B., Tang, P., Hsia, H.C., Leong, P.M., Miller, J.H., Calos, M.P., Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7 (1987), 379–387.
12. Edelstein, M., Vectors used in gene therapy clinical trials. J. Gene Med., 2017 John Wiley & Sons Inc. Hoboken, NJ.
13. Ellis, B.L., Hirsch, M.L., Barker, J.C., Connelly, J.P., Steininger, R.J. 3rd, Porteus, M.H., A survey of ex vivo/in vitro transduction efficiency of mammalian primary cells and cell lines with Nine natural Adeno-associated virus (AAV1-9) and one engineered Adeno-associated virus serotype. Virol. J., 10, 2013, 74.
14. Excoffon, K.J., Koerber, J.T., Dickey, D.D., Murtha, M., Keshavjee, S., Kaspar, B.K., Zabner, J., Schaffer, D.V., Directed evolution of Adeno-associated virus to an infectious respiratory virus. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 3865–3870.
15. Gardner, J.P., Zhu, H., Colosi, P.C., Kurtzman, G.J., Scadden, D.T., Robust, but transient expression of Adeno-associated virus-transduced genes during human T lymphopoiesis. Blood 90 (1997), 4854–4864.
16. Gazdar, A.F., Carney, D.N., Bunn, P.A., Russell, E.K., Jaffe, E.S., Schechter, G.P., Guccion, J.G., Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. Blood 55 (1980), 409–417.
17. Grimm, D., Kay, M.A., From virus evolution to vector revolution: use of naturally occurring serotypes of Adeno-associated virus (AAV) as novel vectors for human gene therapy. Curr. Gene Ther. 3 (2003), 281–304.
18. Hasbrouck, N.C., High, K.A., AAV-mediated gene transfer for the treatment of hemophilia B: problems and prospects. Gene Ther. 15 (2008), 870–875.
19. Horster, A., Teichmann, B., Hormes, R., Grimm, D., Kleinschmidt, J., Sczakiel, G., Recombinant AAV-2 harboring gfp-antisense/ribozyme fusion sequences monitor transduction, gene expression, and show anti-HIV-1 efficacy. Gene Ther. 6 (1999), 1231–1238.
20. Hoxie, J.A., Alpers, J.D., Rackowski, J.L., Huebner, K., Haggarty, B.S., Cedarbaum, A.J., Reed, J.C., Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. Science 234 (1986), 1123–1127.
21. Koerber, J.T., Maheshri, N., Kaspar, B.K., Schaffer, D.V., Construction of diverse Adeno-associated viral libraries for directed evolution of enhanced gene delivery vehicles. Nat. Protoc. 1 (2006), 701–706.
22. Koerber, J.T., Klimczak, R., Jang, J.H., Dalkara, D., Flannery, J.G., Schaffer, D.V., Molecular evolution of Adeno-associated virus for enhanced glial gene delivery. Mol. Ther. 17 (2009), 2088–2095.
23. Kota, J., Handy, C.R., Haidet, A.M., Montgomery, C.L., Eagle, A., Rodino-Klapac, L.R., Tucker, D., Shilling, C.J., Therlfall, W.R., Walker, C.M., Weisbrode, S.E., Janssen, P.M., Clark, K.R., Sahenk, Z., Mendell, J.R., Kaspar, B.K., Follistatin gene delivery enhances muscle growth and strength in nonhuman primates. Sci. Transl. Med., 1, 2009, 6ra15.
24. Kovesdi, I., Hedley, S.J., Adenoviral producer cells. Viruses 2 (2010), 1681–1703.
25. Kwon, I., Schaffer, D.V., Designer gene delivery vectors: molecular engineering and evolution of Adeno-associated viral vectors for enhanced gene transfer. Pharm. Res. 25 (2008), 489–499.
26. Lanteri, M., Giordanengo, V., Hiraoka, N., Fuzibet, J.G., Auberger, P., Fukuda, M., Baum, L.G., Lefebvre, J.C., Altered T cell surface glycosylation in HIV-1 infection results in increased susceptibility to galectin-1-induced cell death. Glycobiology 13 (2003), 909–918.
27. Li, W., Asokan, A., Wu, Z., Van Dyke, T., DiPrimio, N., Johnson, J.S., Govindaswamy, L., Agbandje-McKenna, M., Leichtle, S., Redmond, D.E. Jr., McCown, T.J., Petermann, K.B., Sharpless, N.E., Samulski, R.J., Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles. Mol. Ther. 16 (2008), 1252–1260.
28. Limsirichai, P., Gaj, T., Schaffer, D.V., CRISPR-mediated activation of latent HIV-1 expression. Mol. Ther. 24 (2016), 499–507.
29. Liu, G., Chen, Y.H., He, X., Martins, I., Heth, J.A., Chiorini, J.A., Davidson, B.L., Adeno-associated virus type 5 reduces learning deficits and restores glutamate receptor subunit levels in MPS VII mice CNS. Mol. Ther. 15 (2007), 242–247.
30. Maguire, A.M., High, K.A., Auricchio, A., Wright, J.F., Pierce, E.A., Testa, F., Mingozzi, F., Bennicelli, J.L., Ying, G.S., Rossi, S., Fulton, A., Marshall, K.A., Banfi, S., Chung, D.C., Morgan, J.I., Hauck, B., Zelenaia, O., Zhu, X., Raffini, L., Coppieters, F., De Baere, E., Shindler, K.S., Volpe, N.J., Surace, E.M., Acerra, C., Lyubarsky, A., Redmond, T.M., Stone, E., Sun, J., McDonnell, J.W., Leroy, B.P., Simonelli, F., Bennett, J., Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial. Lancet 374 (2009), 1597–1605.
31. Maguire, C.A., Gianni, D., Meijer, D.H., Shaket, L.A., Wakimoto, H., Rabkin, S.D., Gao, G., Sena-Esteves, M., Directed evolution of Adeno-associated virus for glioma cell transduction. J. Neurooncol. 96 (2010), 337–347.
32. Mann, D.L., O'Brien, S.J., Gilbert, D.A., Reid, Y., Popovic, M., Read-Connole, E., Gallo, R.C., Gazdar, A.F., Origin of the HIV-susceptible human CD4+ cell line H9. AIDS Res. Hum. Retroviruses 5 (1989), 253–255.
33. Mebatsion, T., Finke, S., Weiland, F., Conzelmann, K.K., A CXCR4/CD4 pseudotype rhabdovirus that selectively infects HIV-1 envelope protein-expressing cells. Cell 90 (1997), 841–847.
34. Meerloo, T., Parmentier, H.K., Osterhaus, A.D., Goudsmit, J., Schuurman, H.J., Modulation of cell surface molecules during HIV-1 infection of H9 cells: an immunoelectron microscopic study. AIDS 6 (1992), 1105–1116.
35. Meerloo, T., Sheikh, M.A., Bloem, A.C., de Ronde, A., Schutten, M., van Els, C.A., Roholl, P.J., Joling, P., Goudsmit, J., Schuurman, H.J., Host cell membrane proteins on human immunodeficiency virus type 1 after in vitro infection of H9 cells and blood mononuclear cells. An immuno-electron microscopic study. J. Gen. Virol. 74:Pt 1 (1993), 129–135.
36. Mendelson, E., Grossman, Z., Mileguir, F., Rechavi, G., Carter, B.J., Replication of Adeno-associated virus type 2 in human lymphocytic cells and interaction with HIV-1. Virology 187 (1992), 453–463.
37. Michelfelder, S., Trepel, M., Adeno-associated viral vectors and their redirection to cell-type specific receptors. Adv. Genet. 67 (2009), 29–60.
38. Muller, O.J., Kaul, F., Weitzman, M.D., Pasqualini, R., Arap, W., Kleinschmidt, J.A., Trepel, M., Random peptide libraries displayed on Adeno-associated virus to select for targeted gene therapy vectors. Nat. Biotechnol. 21 (2003), 1040–1046.
39. Muzyczka, N., Use of Adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158 (1992), 97–129.
40. Nault, J.C., Datta, S., Imbeaud, S., Franconi, A., Mallet, M., Couchy, G., Letouze, E., Pilati, C., Verret, B., Blanc, J.F., Balabaud, C., Calderaro, J., Laurent, A., Letexier, M., Bioulac-Sage, P., Calvo, F., Zucman-Rossi, J., Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas. Nat. Genet. 47 (2015), 1187–1193.
41. Oelze, I., Rittner, K., Sczakiel, G., Adeno-associated virus type 2 rep gene-mediated inhibition of basal gene expression of human immunodeficiency virus type 1 involves its negative regulatory functions. J. Virol. 68 (1994), 1229–1233.
42. Park, K.J., Lee, J., Park, J.H., Joh, J.W., Kwon, C.H., Kim, J.W., Adeno-associated virus 2-mediated hepatocellular carcinoma is very rare in Korean patients. Ann. Lab. Med. 36 (2016), 469–474.
43. Pear, W.S., Nolan, G.P., Scott, M.L., Baltimore, D., Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. U. S. A. 90 (1993), 8392–8396.
44. Perabo, L., Buning, H., Kofler, D.M., Ried, M.U., Girod, A., Wendtner, C.M., Enssle, J., Hallek, M., In vitro selection of viral vectors with modified tropism: the Adeno-associated virus display. Mol. Ther. 8 (2003), 151–157.
45. Perabo, L., Goldnau, D., White, K., Endell, J., Boucas, J., Humme, S., Work, L.M., Janicki, H., Hallek, M., Baker, A.H., Buning, H., Heparan sulfate proteoglycan binding properties of Adeno-associated virus retargeting mutants and consequences for their in vivo tropism. J. Virol. 80 (2006), 7265–7269.
46. Ponnazhagan, S., Mukherjee, P., Wang, X.S., Qing, K., Kube, D.M., Mah, C., Kurpad, C., Yoder, M.C., Srour, E.F., Srivastava, A., Adeno-associated virus type 2-mediated transduction in primary human bone marrow-derived CD34+ hematopoietic progenitor cells: donor variation and correlation of transgene expression with cellular differentiation. J. Virol. 71 (1997), 8262–8267.
47. Ponnazhagan, S., Mahendra, G., Kumar, S., Thompson, J.A., Castillas, M. Jr., Conjugate-based targeting of recombinant Adeno-associated virus type 2 vectors by using avidin-linked ligands. J. Virol. 76 (2002), 12900–12907.
48. Popovic, M., Read-Connole, E., Gallo, R.C., T4 positive human neoplastic cell lines susceptible to and permissive for HTLV-III. Lancet 2 (1984), 1472–1473.
49. Popovic, M., Sarngadharan, M.G., Read, E., Gallo, R.C., Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224 (1984), 497–500.
50. Rice, A.P., Mathews, M.B., Trans-activation of the human immunodeficiency virus long terminal repeat sequences, expressed in an adenovirus vector, by the adenovirus E1A 13S protein. Proc. Natl. Acad. Sci. U. S. A. 85 (1988), 4200–4204.
51. Rittner, K., Heilbronn, R., Kleinschmidt, J.A., Sczakiel, G., Adeno-associated virus type 2-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) replication: involvement of p78rep/p68rep and the HIV-1 long terminal repeat. J. Gen. Virol. 73:Pt 11 (1992), 2977–2981.
52. Schnell, M.J., Johnson, J.E., Buonocore, L., Rose, J.K., Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection. Cell 90 (1997), 849–857.
53. Schuhmann, N.K., Pozzoli, O., Sallach, J., Huber, A., Avitabile, D., Perabo, L., Rappl, G., Capogrossi, M.C., Hallek, M., Pesce, M., Buning, H., Gene transfer into human cord blood-derived CD34(+) cells by Adeno-associated viral vectors. Exp. Hematol. 38 (2010), 707–717.
54. Somia, N.V., Miyoshi, H., Schmitt, M.J., Verma, I.M., Retroviral vector targeting to human immunodeficiency virus type 1-infected cells by receptor pseudotyping. J. Virol. 74 (2000), 4420–4424.
55. Song, L., Kauss, M.A., Kopin, E., Chandra, M., Ul-Hasan, T., Miller, E., Jayandharan, G.R., Rivers, A.E., Aslanidi, G.V., Ling, C., Li, B., Ma, W., Li, X., Andino, L.M., Zhong, L., Tarantal, A.F., Yoder, M.C., Wong, K.K. Jr., Tan, M., Chatterjee, S., Srivastava, A., Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo. Cytotherapy 15 (2013), 986–998.
56. Song, L., Li, X., Jayandharan, G.R., Wang, Y., Aslanidi, G.V., Ling, C., Zhong, L., Gao, G., Yoder, M.C., Ling, C., Tan, M., Srivastava, A., High-efficiency transduction of primary human hematopoietic stem cells and erythroid lineage-restricted expression by optimized AAV6 serotype vectors in vitro and in a murine xenograft model in vivo. PLoS One, 8, 2013, e58757.
57. Sonntag, F., Schmidt, K., Kleinschmidt, J.A., A viral assembly factor promotes AAV2 capsid formation in the nucleolus. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 10220–10225.
58. Srivastava, A., Carter, B.J., AAV infection protection from cancer. Hum. Gene Ther. 28 (2017), 323–327.
59. Srivastava, A., Adeno-associated virus-mediated gene transfer. J. Cell. Biochem. 105 (2008), 17–24.
60. Steines, B., Dickey, D.D., Bergen, J., Excoffon, K.J., Weinstein, J.R., Li, X., Yan, Z., Abou Alaiwa, M.H., Shah, V.S., Bouzek, D.C., Powers, L.S., Gansemer, N.D., Ostedgaard, L.S., Engelhardt, J.F., Stoltz, D.A., Welsh, M.J., Sinn, P.L., Schaffer, D.V., Zabner, J., CFTR gene transfer with AAV improves early cystic fibrosis pig phenotypes. JCI Insight, 1, 2016, e88728.
61. Stevenson, M., Zhang, X.H., Volsky, D.J., Downregulation of cell surface molecules during noncytopathic infection of T cells with human immunodeficiency virus. J. Virol. 61 (1987), 3741–3748.
62. Trempe, J.P., Carter, B.J., Alternate mRNA splicing is required for synthesis of Adeno-associated virus VP1 capsid protein. J. Virol. 62 (1988), 3356–3363.
63. Veldwijk, M.R., Sellner, L., Stiefelhagen, M., Kleinschmidt, J.A., Laufs, S., Topaly, J., Fruehauf, S., Zeller, W.J., Wenz, F., Pseudotyped recombinant Adeno-associated viral vectors mediate efficient gene transfer into primary human CD34(+) peripheral blood progenitor cells. Cytotherapy 12 (2010), 107–112.
64. Wagner, J.A., Messner, A.H., Moran, M.L., Daifuku, R., Kouyama, K., Desch, J.K., Manley, S., Norbash, A.M., Conrad, C.K., Friborg, S., Reynolds, T., Guggino, W.B., Moss, R.B., Carter, B.J., Wine, J.J., Flotte, T.R., Gardner, P., Safety and biological efficacy of an Adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus. Laryngoscope 109 (1999), 266–274.
65. Wang, J., Exline, C.M., DeClercq, J.J., Llewellyn, G.N., Hayward, S.B., Li, P.W., Shivak, D.A., Surosky, R.T., Gregory, P.D., Holmes, M.C., Cannon, P.M., Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors. Nat. Biotechnol. 33 (2015), 1256–1263.
66. Wu, Z., Asokan, A., Samulski, R.J., Adeno-associated virus serotypes: vector toolkit for human gene therapy. Mol. Ther. 14 (2006), 316–327.
67. Xiao, X., Li, J., Samulski, R.J., Production of high-titer recombinant Adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72 (1998), 2224–2232.
68. Yin, C., Zhang, T., Qu, X., Zhang, Y., Putatunda, R., Xiao, X., Li, F., Xiao, W., Zhao, H., Dai, S., Qin, X., Mo, X., Young, W.B., Khalili, K., Hu, W., In vivo excision of HIV-1 provirus by saCas9 and multiplex single-Guide RNAs in animal models. Mol. Ther. 25 (2017), 1168–1186.
69. Zhang, P.X., Fuleihan, R.L., Transfer of activation-dependent gene expression into T cell lines by recombinant Adeno-associated virus. Gene Ther. 6 (1999), 182–189.